Dark clouds for biotech

Last week’s abrupt decline in the U.S. #biotech indices look like the beginning of a larger decline.

It could be a dark winter while political machinations sort themselves out.

For some reference, while the iShares Biotech ETF #IBB will likely bounce in the near term, I’ll look for it to eventually trade down slightly below the $100 mark.

November 19, 2024

rob@karriasset.com.au